168 related articles for article (PubMed ID: 25537310)
1. Radioembolization dosimetry: the road ahead.
Smits ML; Elschot M; Sze DY; Kao YH; Nijsen JF; Iagaru AH; de Jong HW; van den Bosch MA; Lam MG
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):261-9. PubMed ID: 25537310
[TBL] [Abstract][Full Text] [Related]
2. A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.
Chiesa C; Mira M; Maccauro M; Romito R; Spreafico C; Sposito C; Bhoori S; Morosi C; Pellizzari S; Negri A; Civelli E; Lanocita R; Camerini T; Bampo C; Carrara M; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):503-8. PubMed ID: 23358402
[TBL] [Abstract][Full Text] [Related]
3. Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres.
Fallahpoor M; Abbasi M; Parach AA; Kalantari F
J Appl Clin Med Phys; 2017 Mar; 18(2):176-180. PubMed ID: 28300366
[TBL] [Abstract][Full Text] [Related]
4. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
[TBL] [Abstract][Full Text] [Related]
5. Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.
Chiesa C; Maccauro M; Romito R; Spreafico C; Pellizzari S; Negri A; Sposito C; Morosi C; Civelli E; Lanocita R; Camerini T; Bampo C; Bhoori S; Seregni E; Marchianò A; Mazzaferro V; Bombardieri E
Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):168-97. PubMed ID: 21386789
[TBL] [Abstract][Full Text] [Related]
6. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
[TBL] [Abstract][Full Text] [Related]
8. Microdosimetric considerations of hepatic radioembolization.
Feinendegen LE
J Nucl Med; 1994 Oct; 35(10):1644-6. PubMed ID: 7931663
[No Abstract] [Full Text] [Related]
9. PET/CT Specificities in
Stephan W; Michel H
PET Clin; 2019 Oct; 14(4):469-476. PubMed ID: 31472744
[TBL] [Abstract][Full Text] [Related]
10. Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method.
Ahmadzadehfar H; Haslerud T; Reichmann K; Meyer C; Habibi E; Fimmers R; Muckle M; Sabet A; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(3):95-8. PubMed ID: 24105253
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization.
Petitguillaume A; Bernardini M; Hadid L; de Labriolle-Vaylet C; Franck D; Desbrée A
J Nucl Med; 2014 Mar; 55(3):405-13. PubMed ID: 24504053
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic Activity Distribution in Radioembolization with Yttrium-90-Labeled Resin Microspheres Using the Body Surface Area Method--A Less than Perfect Model.
Grosser OS; Ulrich G; Furth C; Pech M; Ricke J; Amthauer H; Ruf J
J Vasc Interv Radiol; 2015 Nov; 26(11):1615-21. PubMed ID: 26321017
[TBL] [Abstract][Full Text] [Related]
13. Systematic investigation on the validity of partition model dosimetry for
Hashikin NAA; Yeong CH; Guatelli S; Abdullah BJJ; Ng KH; Malaroda A; Rosenfeld A; Perkins AC
Phys Med Biol; 2017 Aug; 62(18):7342-7356. PubMed ID: 28686171
[TBL] [Abstract][Full Text] [Related]
14. Hepatic structural dosimetry in (90)Y microsphere treatment: a Monte Carlo modeling approach based on lobular microanatomy.
Gulec SA; Sztejnberg ML; Siegel JA; Jevremovic T; Stabin M
J Nucl Med; 2010 Feb; 51(2):301-10. PubMed ID: 20080888
[TBL] [Abstract][Full Text] [Related]
15. Radioembolization of liver tumors with yttrium-90 microspheres.
Ahmadzadehfar H; Biersack HJ; Ezziddin S
Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679
[TBL] [Abstract][Full Text] [Related]
16. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.
Salem R; Thurston KG
J Vasc Interv Radiol; 2006 Oct; 17(10):1571-93. PubMed ID: 17056999
[TBL] [Abstract][Full Text] [Related]
17. Comments on: Intrahepatic Activity Distribution in Radioembolization with Yttrium-90-Labeled Resin Microspheres Using the Body Surface Area Method--A Less than Perfect Model.
Pasciak AS; Bourgeois AC
J Vasc Interv Radiol; 2016 Feb; 27(2):297-8. PubMed ID: 26830949
[No Abstract] [Full Text] [Related]
18. The Unique Role of Fluorodeoxyglucose-PET in Radioembolization.
Bastiaannet R; Lodge MA; de Jong HWAM; Lam MGEH
PET Clin; 2019 Oct; 14(4):447-457. PubMed ID: 31472742
[TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial yttrium 90 microspheres: another treatment option for hepatocellular carcinoma.
Dawson LA
J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):161-4. PubMed ID: 15713916
[No Abstract] [Full Text] [Related]
20. [Radioembolization with (90)Y-labeled microspheres: post-therapeutic therapy validation with Bremsstrahlung-SPECT].
Grober OS; Nultsch M; Laatz K; Ulrich G; Seidensticker R; Pethe A; Dudeck O; Pech M; Knoop BO; Ricke J; Amthauer H; Geworski L
Z Med Phys; 2011 Dec; 21(4):274-80. PubMed ID: 21719264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
